Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingmar Jungner

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Clinical Chemistry and Laboratory Medicine|December 4, 2004
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskGöran Walldius, Ingmar Jungner, Are H Aastveit, et al.
Journal of Hypertension|June 30, 2012
Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individualsPayam Khalili, Johan Sundström, Stanley S Franklin, et al.
Diabetes Research and Clinical Practice|April 27, 2013
Country of birth-specific and gender differences in prevalence of diabetes in SwedenAxel C Carlsson, Per E Wändell, Ebba Hedlund, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Diabetes, Obesity & Metabolism|February 6, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS studyHåkan Malmström, Göran Walldius, Sofia Carlsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS studyMieke Van Hemelrijck, Danielle Harari, Hans Garmo, et al.
BMC Cancer|February 22, 2018
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohortCecilia Bosco, Hans Garmo, Niklas Hammar, et al.
Atherosclerosis|September 22, 2009
Levels of lipids and apolipoproteins in three culturesAmirreza Solhpour, Sahar Parkhideh, Nizal Sarrafzadegan, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|December 4, 2004
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskGöran Walldius, Ingmar Jungner, Are H Aastveit, et al.
Journal of Hypertension|June 30, 2012
Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individualsPayam Khalili, Johan Sundström, Stanley S Franklin, et al.
Diabetes Research and Clinical Practice|April 27, 2013
Country of birth-specific and gender differences in prevalence of diabetes in SwedenAxel C Carlsson, Per E Wändell, Ebba Hedlund, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Diabetes, Obesity & Metabolism|February 6, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS studyHåkan Malmström, Göran Walldius, Sofia Carlsson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS studyMieke Van Hemelrijck, Danielle Harari, Hans Garmo, et al.
BMC Cancer|February 22, 2018
Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohortCecilia Bosco, Hans Garmo, Niklas Hammar, et al.
Atherosclerosis|September 22, 2009
Levels of lipids and apolipoproteins in three culturesAmirreza Solhpour, Sahar Parkhideh, Nizal Sarrafzadegan, et al.
Pageof 7